此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

CBCT 引导的肺结节导航支气管镜检查

2026年8月26日 更新者:Adnan Majid, MD、Beth Israel Deaconess Medical Center

锥形束计算机断层扫描 - 用于周围肺结节的引导导航支气管镜检查:一项随机试验

The purpose of this study is to determine if the cone beam computed tomography (CBCT)-guided navigation bronchoscopy is better in diagnosing lung nodules compared to navigation bronchoscopy alone.

研究概览

详细说明

This clinical trial examines the effectiveness of a treatment comparing it to another known treatment.

The U.S. Food and Drug Administration (FDA) has approved the navigation bronchoscopy as a treatment option for this disease.

The U.S. Food and Drug Administration (FDA) has approved the Cone-Beam CT scan as a treatment option for this disease.

This research study involves a screening period, a procedure and follow up visits.

The names of the study interventions involved in this study are:

  • Computed tomography (CBCT)-guided navigation bronchoscopy (CBCT-guided NB)
  • Navigation bronchoscopy alone

Participants will receive the study procedure and will be followed for up to 6 months.

It is expected that about 136 people will take part in this research study.

研究类型

介入性

注册 (实际的)

20

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Massachusetts
      • Boston、Massachusetts、美国、02215
        • Beth Israel Deaconness Medical Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Participants ≥18 years old.
  • Participants with lesions having an intermediate pre-test probability of malignancy (pCA, 0.05 to 0.65) as determined by Swensen-Mayo nodule risk calculator and in whom bronchoscopic biopsy was determined to be the next best treatment step by the treating pulmonologist.
  • Participants with higher risk lesions (pCA > 0.65) in need of a diagnosis for nonsurgical treatment or prior to surgery.
  • Participants are willing and able to provide informed consent.

Exclusion Criteria:

  • The participant is pregnant as confirmed by urine or serum pregnancy testing.
  • There is a predetermined plan to pursue stereotactic body radiation therapy (SBRT) in the event of a nondiagnostic study procedure in participant's with a nodule in the outer 1/3 lung zone (i.e. The participant would not go on for a CT guided TTNA).
  • Lacked fitness according to physician judgement to undergo bronchoscopy.
  • Contraindication for temporary interruption of the use of anticoagulant therapy.
  • Uncontrolled or irreversible coagulopathy.
  • Known allergy for lidocaine.
  • Uncontrolled pulmonary hypertension.
  • Recent (< 4 weeks) and/or uncontrolled cardiac disease.
  • Compromised upper airway (eg concomitant head and neck cancer or central airway stenosis such that endobronchial access is considered unsafe).
  • ASA classification ≥ 4.
  • COVID-19 positive participant at the time of procedure.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:诊断
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Navigation Bronchoscopy ALONE

This research study involves a screening period, a procedure and follow up visits

  • Procedure Visit Navigation Bronchoscopy Alone
  • Follow-Up Visits at Week 1, 4 and 12

Navigation Bronchoscopy procedure will be performed per product instructions and the institution's standard practice.

其他名称:
  • 注意事项
实验性的:CBCT-GUIDED Navigation Bronchoscopy

This research study involves a screening period, a procedure and follow up visits Procedure Visit- Cone Beam Computed Tomography - Guided Navigation Bronchoscopy for Peripheral Pulmonary Nodules

-Follow-Up Visits at Week 1, 4 and 12

Navigation Bronchoscopy procedure will be performed per product instructions and the institution's standard practice.

其他名称:
  • 注意事项

Per Protocol

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Overall Diagnostic Yield
大体时间:6 months

The overall diagnostic yield will be calculated by adding the number of true positives (TP) for both malignancy and benign disease in the numerator and dividing by the total number of procedures performed for each arm of the study.

Proportions will be compared with the Chi-Square Test as this test is equivalent to the z-test of two proportions (26). A p-value <0.05 will be considered as statistically significant.

6 months

次要结果测量

结果测量
措施说明
大体时间
Overall Incidence of Procedure-related Complications
大体时间:6 months

To compare complications between navigational bronchoscopy alone and CBCT guided bronchoscopy.

6 months
Additional Diagnostic Procedures in Navigational Bronchoscopy Alone and CBCT Guided Bronchoscopy.
大体时间:6 Months

To compare the need of additional diagnostic procedures in navigational bronchoscopy alone and CBCT guided bronchoscopy.

6 Months
Navigational Time in Bronchoscopy Alone and CBCT Guided Bronchoscopy.
大体时间:6 Months

To compare the navigational time defined as the time between the start of catheter driving after registration until catheter is parked for biopsy.

6 Months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Adnan Majid, MD、Beth Israel Deaconess Medical Center

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2021年3月5日

初级完成 (实际的)

2023年4月12日

研究完成 (实际的)

2023年4月12日

研究注册日期

首次提交

2021年2月14日

首先提交符合 QC 标准的

2021年2月14日

首次发布 (实际的)

2021年2月17日

研究记录更新

最后更新发布 (实际的)

2026年9月22日

上次提交的符合 QC 标准的更新

2026年8月26日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to Sponsor Investigator or designee. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

IPD 共享时间框架

Data can be shared no earlier than 1 year following the date of publication

IPD 共享访问标准

Contact the Beth Israel Deaconess Medical Center Technology Ventures Office at tvo@bidmc.harvard.edu

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 国际碳纤维联合会

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅